United States - English - NLM (National Library of Medicine)

uriel pharmacy inc. - cucurbita pepo flower (unii: 413mgp37hq) (cucurbita pepo flower - unii:413mgp37hq), fluorapatite (unii: m4cm1h238j) (fluorapatite - unii:m4cm1h238j), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), lead carbonate (unii: 43m0p24l2b) (lead - unii:2p299v784p) - directions: for oral use only. use: for healthy teeth and bone development.

Singapore - English - HSA (Health Sciences Authority)

humedical (s) pte. ltd. - orthopaedics - the osteodrive mcu-470 handpiece is intended for use with the pc- 47x power console in surgical procedures involving drilling, reaming, wire or pin driving, burring and cutting bone or hard tissue. the osteodrive mci-270 handpiece is intended for use with the pc- 47x power console in surgical procedures involving drilling, wire driving, burring, and the cutting of bone, metal or hard tissue – specifically, for hand and foot, and craniomaxillofacial surgery. this equipment is not suitable for cranial perforations and sternotomies.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow - sical is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. sical a is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. sical is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: fractionated coconut oil; butylated hydroxyanisole; butylated hydroxytoluene; gelatin; glycerol; sorbitol solution (70 per cent) (non-crystallising); purified water; iron oxide red; iron oxide yellow; titanium dioxide - calcitriol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.,calcitriol is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss.,calcitriol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: butylated hydroxyanisole; iron oxide red; purified water; gelatin; iron oxide yellow; fractionated coconut oil; glycerol; sorbitol solution (70 per cent) (non-crystallising); butylated hydroxytoluene - calciprox is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. calciprox is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. calciprox is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - calcitriol, quantity: 0.25 microgram - capsule, soft - excipient ingredients: gelatin; butylated hydroxyanisole; glycerol; iron oxide red; iron oxide yellow; titanium dioxide; medium chain triglycerides; butylated hydroxytoluene; maize starch; sorbitol; mannitol - for the management of established post-menopausal osteoporosis by increasing calcium absorption, elevating circulating levels of calcitriol, and reducing vertebral fracture frequency. for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. for the treatment of hypoclacamia in patients with uraemic osteodystrophy, hypoparathyroidism and vitamin d resistant rickets. indications as at 4 march 2004: rocaltrol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of a traumatic fracture. rocaltrol is also indicated for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. rocaltrol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in

Israel - English - Ministry of Health

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

Israel - English - Ministry of Health

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

Israel - English - Ministry of Health

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.5 mcg - vitamin d and analogues - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease)- primary and tertiary. - rickets and osteomalacia. - osteoporosis.